[#item_full_content]Is CMS Circumventing FDA Drug Approval Standards While Congress Moves to Shut the Hemp Market Down?With Congress tightening federal THC limits and the FDA still evaluating cannabinoid safety standards, critics are asking why Medicare is moving forward with reimbursed CBD products that lack validated dose forms, pharmacokinetic benchmarks, or identified pharmaceutical-grade sources.
Read More
